Both type 1 and type 2 diabetes are associated with an increased risk of atherosclerotic
cardiovascular disease (CVD). Research based on human-first or bedside-to-bench …

Introduction There is few effective biomarkers for diagnosing nonalcoholic fatty liver disease
(NAFLD) in clinical practice. This study was aimed to investigate the predictive ability of …

A prevailing notion is that increased glucose uptake in response to hyperglycemia in cells
involved in atherosclerosis contributes to the increased risk of cardiovascular complications …

Background: Pathogenetic mechanisms of the progression of NAFL to advanced NASH
coupled with potential noninvasive biomarkers and novel therapeutic targets are active …

Neonatal hypoxia-ischemia (HI) is a major cause of perinatal death and long-term
disabilities worldwide. Post-ischemic neuroinflammation plays a pivotal role in HI …

Objective Given the high prevalence of non-alcoholic fatty liver disease (NAFLD) and its
potential to progress to liver fibrosis, it is crucial to identify the presence of NAFLD in patients …

目的: 探讨高密度脂蛋白(HDL) 与骨髓增生异常综合征(MDS) 预后的关系. 方法: 收集2013 年1
月—2019 年1 月224 例初诊MDS 患者的临床资料并进行统计分析. 结果: 全部患者分为HDL≥ …

Atherosclerosis, characterized by arterial fat deposits, is the root cause of many
cardiovascular diseases. Plaque deposition results from a series of events initiated by …

Relationship between high density lipoprotein and prognosis of patients with
myelodysplastic syndrome Homepage Journals 1.{{journal.titleEn}} {{journal.titleEn}} {{journal.titleEn}} …